Brussels, Belgium

Martine Demoustier

This inventor holds 1 USPTO granted patent. Top assignee: Ucb S.a.. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martine Demoustier: Innovator in Pharmaceutical Nanotechnology

Introduction

Martine Demoustier is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of pharmaceutical compositions, particularly through her innovative work involving nanocapsules. Her research focuses on enhancing the delivery of therapeutically active substances, which has important implications for medical treatments.

Latest Patents

Martine Demoustier holds a patent for "Pharmaceutical compositions containing nanocapsules." This patent describes a pharmaceutical composition in the form of a colloidal suspension of nanocapsules. The composition includes an oily phase consisting of an oil with a dissolved surfactant and a plurality of nanocapsules with a diameter of less than 500 nanometers. These nanocapsules encapsulate an aqueous phase that contains a solution or suspension of a therapeutically active substance, a surfactant, and optionally ethanol. The walls of the nanocapsules are formed from poly(alkyl 2-cyanoacrylate), where the alkyl radical has 1 to 6 carbon atoms. This composition is particularly suitable for the oral administration of polypeptides and polysaccharides.

Career Highlights

Martine Demoustier is associated with UCB S.A., a global biopharmaceutical company. Her work at UCB has allowed her to explore and develop innovative pharmaceutical solutions that address critical health challenges. Her dedication to research and development has positioned her as a key figure in her field.

Collaborations

Throughout her career, Martine has collaborated with notable colleagues, including Henri Vranckx and Michel Deleers. These collaborations have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Martine Demoustier's contributions to pharmaceutical nanotechnology exemplify the impact of innovation in healthcare. Her work continues to pave the way for new therapeutic approaches that enhance patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…